Literature DB >> 18474611

The MODY1 gene for hepatocyte nuclear factor 4alpha and a feedback loop control COUP-TFII expression in pancreatic beta cells.

Anaïs Perilhou1, Cécile Tourrel-Cuzin, Pili Zhang, Ilham Kharroubi, Haiyan Wang, Véronique Fauveau, Donald K Scott, Claes B Wollheim, Mireille Vasseur-Cognet.   

Abstract

Pancreatic islet beta cell differentiation and function are dependent upon a group of transcription factors that maintain the expression of key genes and suppress others. Knockout mice with the heterozygous deletion of the gene for chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) or the complete disruption of the gene for hepatocyte nuclear factor 4alpha (HNF4alpha) in pancreatic beta cells have similar insulin secretion defects, leading us to hypothesize that there is transcriptional cross talk between these two nuclear receptors. Here, we demonstrate specific HNF4alpha activation of a reporter plasmid containing the COUP-TFII gene promoter region in transfected pancreatic beta cells. The stable association of the endogenous HNF4alpha with a region of the COUP-TFII gene promoter that contains a direct repeat 1 (DR-1) binding site was revealed by chromatin immunoprecipitation. Mutation experiments showed that this DR-1 site is essential for HNF4alpha transactivation of COUP-TFII. The dominant negative suppression of HNF4alpha function decreased endogenous COUP-TFII expression, and the specific inactivation of COUP-TFII by small interfering RNA caused HNF4alpha mRNA levels in 832/13 INS-1 cells to decrease. This positive regulation of HNF4alpha by COUP-TFII was confirmed by the adenovirus-mediated overexpression of human COUP-TFII (hCOUP-TFII), which increased HNF4alpha mRNA levels in 832/13 INS-1 cells and in mouse pancreatic islets. Finally, hCOUP-TFII overexpression showed that there is direct COUP-TFII autorepression, as COUP-TFII occupies the proximal DR-1 binding site of its own gene in vivo. Therefore, COUP-TFII may contribute to the control of insulin secretion through the complex HNF4alpha/maturity-onset diabetes of the young 1 (MODY1) transcription factor network operating in beta cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474611      PMCID: PMC2447131          DOI: 10.1128/MCB.01191-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  27 in total

1.  Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements.

Authors:  H Nakshatri; P Bhat-Nakshatri
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

2.  Cell type specific regulation of COUP-TF II promoter activity.

Authors:  A Soosaar; K Neuman; H O Nornes; T Neuman
Journal:  FEBS Lett       Date:  1996-08-05       Impact factor: 4.124

3.  Ligand binding was acquired during evolution of nuclear receptors.

Authors:  H Escriva; R Safi; C Hänni; M C Langlois; P Saumitou-Laprade; D Stehelin; A Capron; R Pierce; V Laudet
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

4.  Negative cyclic AMP response elements in the promoter of the L-type pyruvate kinase gene.

Authors:  L Gourdon; D Q Lou; M Raymondjean; M Vasseur-Cognet; A Kahn
Journal:  FEBS Lett       Date:  1999-10-01       Impact factor: 4.124

5.  Chicken ovalbumin upstream promoter-transcription factor II, a new partner of the glucose response element of the L-type pyruvate kinase gene, acts as an inhibitor of the glucose response.

Authors:  D Q Lou; M Tannour; L Selig; D Thomas; A Kahn; M Vasseur-Cognet
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

6.  Protein kinase A-dependent phosphorylation modulates DNA-binding activity of hepatocyte nuclear factor 4.

Authors:  B Viollet; A Kahn; M Raymondjean
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

7.  The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion.

Authors:  Rana K Gupta; Marko Z Vatamaniuk; Catherine S Lee; Reed C Flaschen; James T Fulmer; Franz M Matschinsky; Stephen A Duncan; Klaus H Kaestner
Journal:  J Clin Invest       Date:  2005-03-03       Impact factor: 14.808

8.  Functional study of the E276Q mutant hepatocyte nuclear factor-4alpha found in type 1 maturity-onset diabetes of the young: impaired synergy with chicken ovalbumin upstream promoter transcription factor II on the hepatocyte nuclear factor-1 promoter.

Authors:  L Suaud; Y Hemimou; P Formstecher; B Laine
Journal:  Diabetes       Date:  1999-05       Impact factor: 9.461

9.  Essential role of chicken ovalbumin upstream promoter-transcription factor II in insulin secretion and insulin sensitivity revealed by conditional gene knockout.

Authors:  Pascale Bardoux; Pili Zhang; Daisy Flamez; Anaïs Perilhou; Tiphaine Aguirre Lavin; Jean-François Tanti; Karine Hellemans; Emmanuel Gomas; Cécile Godard; Fabrizio Andreelli; Maria Antonietta Buccheri; Axel Kahn; Yannick Le Marchand-Brustel; Rémy Burcelin; Frans Schuit; Mireille Vasseur-Cognet
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

Review 10.  The nuclear receptor superfamily: the second decade.

Authors:  D J Mangelsdorf; C Thummel; M Beato; P Herrlich; G Schütz; K Umesono; B Blumberg; P Kastner; M Mark; P Chambon; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

View more
  16 in total

1.  Identification of the Flavonoid Luteolin as a Repressor of the Transcription Factor Hepatocyte Nuclear Factor 4α.

Authors:  Juan Li; Jun Inoue; Jung-Min Choi; Shugo Nakamura; Zhen Yan; Shinya Fushinobu; Haruhiko Kamada; Hisanori Kato; Tsutomu Hashidume; Makoto Shimizu; Ryuichiro Sato
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

Review 2.  Proof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinations.

Authors:  Asfar S Azmi; Zhiwei Wang; Philip A Philip; Ramzi M Mohammad; Fazlul H Sarkar
Journal:  Mol Cancer Ther       Date:  2010-11-01       Impact factor: 6.261

3.  The transcription factor COUP-TFII is negatively regulated by insulin and glucose via Foxo1- and ChREBP-controlled pathways.

Authors:  Anaïs Perilhou; Cécile Tourrel-Cuzin; Ilham Kharroubi; Carole Henique; Véronique Fauveau; Tadahiro Kitamura; Christophe Magnan; Catherine Postic; Carina Prip-Buus; Mireille Vasseur-Cognet
Journal:  Mol Cell Biol       Date:  2008-09-02       Impact factor: 4.272

4.  Novel mechanisms of regulation of the expression and transcriptional activity of hepatocyte nuclear factor 4α.

Authors:  Shangdong Guo; Hong Lu
Journal:  J Cell Biochem       Date:  2018-09-07       Impact factor: 4.429

Review 5.  HNF4α--role in drug metabolism and potential drug target?

Authors:  Wendy W Hwang-Verslues; Frances M Sladek
Journal:  Curr Opin Pharmacol       Date:  2010-12       Impact factor: 5.547

Review 6.  Coup d'Etat: an orphan takes control.

Authors:  Fu-Jung Lin; Jun Qin; Ke Tang; Sophia Y Tsai; Ming-Jer Tsai
Journal:  Endocr Rev       Date:  2011-01-21       Impact factor: 19.871

7.  The nutritional induction of COUP-TFII gene expression in ventromedial hypothalamic neurons is mediated by the melanocortin pathway.

Authors:  Lina Sabra-Makke; Cécile Tourrel-Cuzin; Raphaël G P Denis; Marthe Moldes; Jean-Paul Pégorier; Serge Luquet; Mireille Vasseur-Cognet; Pascale Bossard
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

8.  Hypothalamic ventromedial COUP-TFII protects against hypoglycemia-associated autonomic failure.

Authors:  Lina Sabra-Makke; Micol Maritan; Julien Planchais; Marie Boutant; Jean-Paul Pégorier; Patrick C Even; Mireille Vasseur-Cognet; Pascale Bossard
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

Review 9.  Multiple roles of COUP-TFII in cancer initiation and progression.

Authors:  Lacey M Litchfield; Carolyn M Klinge
Journal:  J Mol Endocrinol       Date:  2012-10-10       Impact factor: 5.098

10.  Glucose-dependent regulation of NR2F2 promoter and influence of SNP-rs3743462 on whole body insulin sensitivity.

Authors:  Marie Boutant; Oscar Henrique Pereira Ramos; Cécile Lecoeur; Emmanuel Vaillant; Julien Philippe; Pili Zhang; Anaïs Perilhou; Beatriz Valcarcel; Sylvain Sebert; Mario-Ritta Jarvelin; Beverley Balkau; Donald Scott; Philippe Froguel; Martine Vaxillaire; Mireille Vasseur-Cognet
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.